0001209191-20-011567.txt : 20200221
0001209191-20-011567.hdr.sgml : 20200221
20200221164347
ACCESSION NUMBER: 0001209191-20-011567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200220
FILED AS OF DATE: 20200221
DATE AS OF CHANGE: 20200221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mamluk Roni
CENTRAL INDEX KEY: 0001647053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37500
FILM NUMBER: 20640691
MAIL ADDRESS:
STREET 1: CHIASMA, INC.
STREET 2: 60WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIASMA, INC
CENTRAL INDEX KEY: 0001339469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-928-5300
MAIL ADDRESS:
STREET 1: 460 TOTTEN POND ROAD
STREET 2: SUITE 530
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: CHIASMA INC
DATE OF NAME CHANGE: 20050922
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-20
0
0001339469
CHIASMA, INC
CHMA
0001647053
Mamluk Roni
C/O CHIASMA, INC.
140 KENDRICK STREET, BUILDING C EAST
NEEDHAM
MA
02494
1
0
0
0
Common Stock
2020-02-20
4
M
0
82186
0.09
A
82186
D
Common Stock
2020-02-20
4
S
0
82186
4.54
D
0
D
Stock Option (Right to Buy)
3.00
2019-12-20
4
M
0
82186
0.00
D
2022-09-12
Common Stock
82186
0
D
The sale was effected pursuant to a Rule 10b5-1 trading plan dated May 17, 2019 adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.45 to $4.60, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This option is fully vested and exercisable.
/s/ Mark J. Fitzpatrick, Attorney-in-Fact
2020-02-21